Bardin Hill Management Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bardin Hill Management Partners’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-208,991	Closed	-$7.87M	–	106
2021 Q1	$7.87M	Buy	+208,991	New	+$5.21M	1.46%	20

Bardin Hill Management Partners's FPRX Position: Q2 2021 in Review

Bardin Hill Management Partners sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 208,991 shares — an estimated $7.87M sold.

Bardin Hill Management Partners first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $7.87M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Bardin Hill Management Partners reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Bardin Hill Management Partners sold 208,991 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $7.87M.
Bardin Hill Management Partners first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Bardin Hill Management Partners's Five Prime Therapeutics, Inc. position peaked at $7.87M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Bardin Hill Management Partners's 13F filing for Q2 2021, filed 16 Aug 2021.